Name | Rivaroxaban | CAS# | 366789-02-8 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders. |
Get all suppliers by the below link:
2024-07-15 |
Rivaroxaban
Price: Inquiry |
2019-03-05 |
Rivaroxaban
Price: ¥198.0 |
2020-01-06 |
BAY 59-7939 (Rivaroxaban)
Price: $200.0 |
2021-07-26 |
Rivaroxaban
Price: $Inquiry |
2024-01-09 |
Rivaroxaban
Price: $Inquiry |
2017-10-27 |
Rivaroxaban
Price: ¥Inquiry |
2017-06-15 |
Rivaroxaban
Price: ¥Inquiry |
2017-07-07 |
Rivaroxaban
Price: ¥Inquiry |
2017-06-13 |
Rivaroxaban
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved